RFAI
Rights 1/20PubCo NYBRF Acquisition Corp II
Target Nanyang Biologics · Biotech
Close odds
73%
High
Price
$10.85
+6.9% vs trust
Status
Near Effective
CIK
0002012807
IPO date
2024-05-17
Market cap
483.94M
Days to deadline
114d
SEC tickers
RFAI, RFAIR, RFAIU
Rights
Yes 1/20
Warrants
Yes @ $11.5
Rights source
sec-ticker-R
Sponsor
RF Acquisition
S-4 / F-4 filer
holdco · NYB Holdings Ltd
PubCo ticker
NYB
Live tape
Common, rights, and warrants when Nasdaq lists them. Delayed exchange data.
Loading quotes…
Loading chart…
S-4 study: rights conversion did not change across amendments for this name. See amendment impact
S-4 amendment timeline
Shrinking gaps mean the deal is progressing. The tag says whether that filing cleared a checklist, dropped a hurdle, or repriced the deal.
- F-4/A2026-07-13Checklist
F-4/A
- F-4/A2026-06-16Hurdle-clearing
F-4/A
- F-4/A2026-06-03Hurdle-clearing
F-4/A
- F-4/A2026-05-05Checklist
F-4/A
- F-4/A2026-04-17Checklist
F-4/A
- F-42026-03-19Initial filing
F-4
Your notes
Saved on this device only.